Crizotinib safety profile in elderly and non-elderly patients (pts) with advanced ALK plus non-small cell lung cancer (NSCLC)

作者： F Blackhall , AT Shaw , PA Jaenne , DW Kim , KD Wilner

DOI:

关键词: